AKT1 and breast cancer: To further examine whether ellagic acid could suppress breast cancer growth by inhibiting angiogenesis, tumor tissues were stained with specific antibodies against CD31, P-VEGFR2 (Tyr 1175), P-AKT, and P-JNK in Fig. 5b.